Does LAMIVUDINE Cause Foetal exposure during pregnancy? 1,905 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,905 reports of Foetal exposure during pregnancy have been filed in association with LAMIVUDINE (Lamivudine and Zidovudine). This represents 11.4% of all adverse event reports for LAMIVUDINE.
1,905
Reports of Foetal exposure during pregnancy with LAMIVUDINE
11.4%
of all LAMIVUDINE reports
254
Deaths
229
Hospitalizations
How Dangerous Is Foetal exposure during pregnancy From LAMIVUDINE?
Of the 1,905 reports, 254 (13.3%) resulted in death, 229 (12.0%) required hospitalization, and 15 (0.8%) were considered life-threatening.
Is Foetal exposure during pregnancy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LAMIVUDINE. However, 1,905 reports have been filed with the FAERS database.
What Other Side Effects Does LAMIVUDINE Cause?
Virologic failure (1,894)
Drug resistance (1,889)
Pathogen resistance (1,733)
Viral mutation identified (1,631)
Treatment failure (933)
Exposure during pregnancy (846)
Drug interaction (744)
Drug ineffective (726)
Immune reconstitution inflammatory syndrome (625)
Depression (594)
What Other Drugs Cause Foetal exposure during pregnancy?
ACETAMINOPHEN\HYDROCODONE (5,085)
ACETAMINOPHEN\OXYCODONE (5,042)
OXYCODONE (4,819)
ACETAMINOPHEN (3,153)
LAMOTRIGINE (2,985)
MORPHINE (2,839)
LEVETIRACETAM (2,604)
HYDROMORPHONE (2,557)
BUPRENORPHINE (2,538)
TRAMADOL (2,120)
Which LAMIVUDINE Alternatives Have Lower Foetal exposure during pregnancy Risk?
LAMIVUDINE vs LAMIVUDINE\NEVIRAPINE\ZIDOVUDINE
LAMIVUDINE vs LAMIVUDINE\TENOFOVIR
LAMIVUDINE vs LAMIVUDINE\TENOFOVIR DISOPROXIL
LAMIVUDINE vs LAMIVUDINE\ZIDOVUDINE
LAMIVUDINE vs LAMOTRIGINE